Furthermore, combined blockade of PD-L1 and Lymphocyte-activation gene 3 (LAG3) immune inhibitory molecules accelerated clearance of non-lethal P. yoelii blood-stage malaria by improving CD4+ T cell functions and increasing antibody titres (33). The gene discussed is LAG3; the disease is malaria.